SCHEMBL18708347

SCHEMBL18708347

Cc1nc(-c2ccccc2)nc2oc3ccccc3c12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.55
▸ KMT2A Q03164 5/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ RAB9A P51151 2/20 0.55
▸ HTT P42858 2/20 0.55
▸ NPC1 O15118 1/20 0.55
▸ LMNA P02545 5/20 0.44
▸ TSHR P16473 2/20 0.43
▸ ALDH1A1 P00352 5/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ POLB P06746 3/20 0.41
▸ GLA P06280 1/20 0.41
▸ HPGD P15428 2/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ HSD17B10 Q99714 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ DUSP3 P51452 1/20 0.39
▸ PTPN5 P54829 1/20 0.39
▸ PTPN11 Q06124 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19169219 0.97 SMN1; SMN2 (0.52) SMN1; SMN2KMT2AMEN1RAB9AHTT
SCHEMBL29327097 0.85 KMT2A (0.54) SMN1; SMN2KMT2AMEN1RAB9AHTT
SCHEMBL19170197 0.84 SMN1; SMN2 (0.43) SMN1; SMN2KMT2AMEN1RAB9AHTT
SCHEMBL16902387 0.83 KMT2A (0.43) SMN1; SMN2KMT2AMEN1RAB9AHTT
SCHEMBL18017783 0.81 MEN1 (0.45) SMN1; SMN2KMT2AMEN1RAB9AHTT
SCHEMBL18553273 0.81 KMT2A (0.46) SMN1; SMN2KMT2AMEN1RAB9AHTT
SCHEMBL18017879 0.81 MEN1 (0.45) SMN1; SMN2KMT2AMEN1RAB9AHTT
SCHEMBL18017923 0.81 MEN1 (0.45) SMN1; SMN2KMT2AMEN1RAB9AHTT
SCHEMBL19169641 0.81 SMN1; SMN2 (0.43) SMN1; SMN2KMT2AMEN1RAB9AHTT
SCHEMBL19161199 0.81 ATM (0.42) SMN1; SMN2KMT2AMEN1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021135183-A1 ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS 陕西莱特光电材料股份有限公司 2021-07-08 — — WO disclosed
US-20170213984-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME LG CHEM, LTD. (KR) 2017-07-27 — — US disclosed
US-20170098778-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE, ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-04-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170098778-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE, ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OXER1, OR10J3, OCIAD1 SMN1; SMN2 4691/4885KMT2A 4483/4885MEN1 3172/4885
US-20170213984-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, NOS1, NOLC1 SMN1; SMN2 3568/4885KMT2A 1423/4885MEN1 197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback